Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Earle O. Assanah"'
Autor:
Richard P. Junghans, N. Joseph Espat, Robin Davies, Earle O. Assanah, Brian F. Stainken, Qiangzhong Ma, Mitchell Thorn, Pranay D. Khare, Gary R. Point, Wesley Mooring, Li Juan Wang, Elise McCormack, Rachel A. Burga, Steven C. Katz
Supplemental Figure 1. In vitro cytotoxicity assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e4f36b3128e8a08781410abb288250
https://doi.org/10.1158/1078-0432.22458323
https://doi.org/10.1158/1078-0432.22458323
Autor:
Richard P. Junghans, N. Joseph Espat, Robin Davies, Earle O. Assanah, Brian F. Stainken, Qiangzhong Ma, Mitchell Thorn, Pranay D. Khare, Gary R. Point, Wesley Mooring, Li Juan Wang, Elise McCormack, Rachel A. Burga, Steven C. Katz
Purpose: Chimeric antigen receptor–modified T cells (CAR-T) have demonstrated encouraging results in early-phase clinical trials. Successful adaptation of CAR-T technology for CEA-expressing adenocarcinoma liver metastases, a major cause of death i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c749b8413a71355a55dddb9a20c880e
https://doi.org/10.1158/1078-0432.c.6523904.v1
https://doi.org/10.1158/1078-0432.c.6523904.v1
Autor:
Richard P. Junghans, N. Joseph Espat, Robin Davies, Earle O. Assanah, Brian F. Stainken, Qiangzhong Ma, Mitchell Thorn, Pranay D. Khare, Gary R. Point, Wesley Mooring, Li Juan Wang, Elise McCormack, Rachel A. Burga, Steven C. Katz
Supplemental Figure 4. Cytokine response to treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07639feef77b2ee62051a41eed87b308
https://doi.org/10.1158/1078-0432.22458314
https://doi.org/10.1158/1078-0432.22458314
Autor:
Richard P. Junghans, N. Joseph Espat, Robin Davies, Earle O. Assanah, Brian F. Stainken, Qiangzhong Ma, Mitchell Thorn, Pranay D. Khare, Gary R. Point, Wesley Mooring, Li Juan Wang, Elise McCormack, Rachel A. Burga, Steven C. Katz
Supplemental Figure 3. Radiographic studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc3ca32bc6c13ae1f09ab26cef4d090
https://doi.org/10.1158/1078-0432.22458317
https://doi.org/10.1158/1078-0432.22458317
Autor:
Richard P. Junghans, N. Joseph Espat, Robin Davies, Earle O. Assanah, Brian F. Stainken, Qiangzhong Ma, Mitchell Thorn, Pranay D. Khare, Gary R. Point, Wesley Mooring, Li Juan Wang, Elise McCormack, Rachel A. Burga, Steven C. Katz
Supplemental Figure 2. Flow cytometry gating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa7e5a7eacdefc366bf6ba0e0a7d272
https://doi.org/10.1158/1078-0432.22458320.v1
https://doi.org/10.1158/1078-0432.22458320.v1
Autor:
Mitchell Thorn, Richard P. Junghans, Gary Point, Qiangzhong Ma, Elise McCormack, Li Juan Wang, Pranay D. Khare, Robin Davies, Wesley Mooring, Rachel A. Burga, Steven C. Katz, N. Joseph Espat, Brian F. Stainken, Earle O. Assanah
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 21(14)
Purpose: Chimeric antigen receptor–modified T cells (CAR-T) have demonstrated encouraging results in early-phase clinical trials. Successful adaptation of CAR-T technology for CEA-expressing adenocarcinoma liver metastases, a major cause of death i